Pretreatment with Oxygen Protects Rat Kidney from Cisplatin Nephrotoxicity

REFERENCES

• Livingston RB. Cisplatin in the treatment of solid tumors: Effect of dose and schedule. J Natl Cancer Inst. 1989 May 10;81(10):724–725.
   PubMedGoogle Scholar
• Arany I, Safirstein RL. Cisplatin nephrotoxicity. Semin Nephrol. 2003 Sep;23(5):460–464.
   PubMed Web of Science ®Google Scholar
• Berns JS, Ford PA. Renal toxicities of antineoplastic drugs and bone marrow transplantation. Semin Nephrol. 1997 Jan;17(1):54–66.
   PubMedGoogle Scholar
• Santoso JT, Lucci JA III, Coleman RL, Schafer I, Hannigan EV. Saline, mannitol, and furosemide hydration in acute cisplatin nephrotoxicity: A randomized trial. Cancer Chemother Pharmacol. 2003 Jul;52(1):13–18.
   PubMed Web of Science ®Google Scholar
• Taguchi T, Nazneen A, Abid MR, Razzaque MS. Cisplatin-associated nephrotoxicity and pathological events. Contrib Nephrol. 2005;148:107–121.
   PubMed Web of Science ®Google Scholar
• Bonventre JV. Kidney ischemic preconditioning. Curr Opin Nephrol Hypertens. 2002 Jan;11(1):43–48.
   PubMed Web of Science ®Google Scholar
• Mohammadhosseiniakbari H, Rasoulian B, Noroozzadeh A, The effect of short ischemic periods in reducing subsequent rat renal ischemic injury. Physiology and Pharmacology. 2008;12(2):149–157 [in Persian].
   Google Scholar
• Torras J, Herrero-Fresneda I, Lloberas N, Riera M, Ma CJ, Ma GJ. Promising effects of ischemic preconditioning in renal transplantation. Kidney Int. 2002 Jun;61(6):2218–2227.
   PubMed Web of Science ®Google Scholar
• Rasoulian B, Mohammadhosseniakbari H, Kadkhodaee M, Preconditioning with oxygen attenuates rat renal ischemia-reperfusion injury. J Surg Res. 2008 May 15;146(2):282–288.
   PubMed Web of Science ®Google Scholar
• Cetin R, Devrim E, Kilicoglu B, Avci A, Candir O, Durak I. Cisplatin impairs antioxidant system and causes oxidation in rat kidney tissues: Possible protective roles of natural antioxidant foods. J Appl Toxicol. 2006 Jan;26(1):42–46.
   PubMed Web of Science ®Google Scholar
• Tahepold P, Valen G, Starkopf J, Kairane C, Zilmer M, Vaage J. Pretreating rats with hyperoxia attenuates ischemia-reperfusion injury of the heart. Life Sci. 2001 Feb 23;68(14): 1629–1640.
   PubMed Web of Science ®Google Scholar
• Tinits P. Oxygen therapy and oxygen toxicity. Ann Emerg Med. 1983 May;12(5):321–328.
   PubMed Web of Science ®Google Scholar
• Shimeda Y, Hirotani Y, Akimoto Y, Protective effects of capsaicin against cisplatin-induced nephrotoxicity in rats. Biological and Pharmaceutical Bulletin. 2005 Sep;28(9):1635–1638.
   PubMed Web of Science ®Google Scholar
• Behling EB, Sendao MC, Francescato HD, Antunes LM, Costa RS, Bianchi Mde L. Comparative study of multiple dosage of quercetin against cisplatin-induced nephrotoxicity and oxidative stress in rat kidneys. Pharmacol Rep. 2006 Jul–Aug;58(4):526–532.
   PubMed Web of Science ®Google Scholar
• Cohen G, Dembiec D, Marcus J. Measurement of catalase activity in tissue extracts. Anal Biochem. 1970 Mar;34:30–38.
   PubMed Web of Science ®Google Scholar
• Paoletti F, Mocali A. Determination of superoxide dismutase activity by purely chemical system based on NAD(P)H oxidation. Methods Enzymol. 1990;186:209–220.
   PubMed Web of Science ®Google Scholar
• Tietze F. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: Applications to mammalian blood and other tissues. Anal Biochem. 1969 Mar;27(3):502–522.
   PubMed Web of Science ®Google Scholar
• Satoh K. Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method. Clin Chim Acta. 1978 Nov 15;90(1):37–43.
   PubMed Web of Science ®Google Scholar
• Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7; 72:248–254.
   PubMed Web of Science ®Google Scholar
• Solez K, Kramer EC, Fox JA, Heptinstall RH. Medullary plasma flow and intravascular leukocyte accumulation in acute renal failure. Kidney Int. 1974 Jul;6(1):24–37.
   PubMedGoogle Scholar
• Matsushima H, Yonemura K, Ohishi K, Hishida A. The role of oxygen free radicals in cisplatin-induced acute renal failure in rats. J Lab Clin Med. 1998 Jun;131(6):518–526.
   PubMed Web of Science ®Google Scholar
• Ali BH, Al Moundhri MS. Agents ameliorating or augmenting the nephrotoxicity of cisplatin and other platinum compounds: A review of some recent research. Food Chem Toxicol. 2006 Aug;44(8):1173–1183.
   PubMed Web of Science ®Google Scholar
• Appenroth D, Winnefeld K, Schroter H, Rost M. Beneficial effect of acetylcysteine on cisplatin nephrotoxicity in rats. J Appl Toxicol. 1993;13(3):189–192.
   PubMed Web of Science ®Google Scholar
• Sheikh-Hamad D, Timmins K, Jalali Z. Cisplatin-induced renal toxicity: Possible reversal by N-acetylcysteine. J Am Soc Nephrol. 1997 Oct;8(10):1640–1645.
   PubMed Web of Science ®Google Scholar
• Nisar S, Feinfeld DA. N-acetylcysteine as salvage therapy for cisplatin nephrotoxicity. Ren Fail. 2002 Jul; 24(4):529–533.
   PubMed Web of Science ®Google Scholar
• Ajith TA, Jose N, Janardhanan KK. Amelioration of cisplatin induced nephrotoxicity in mice by ethyl acetate extract of a polypore fungus, Phellinus rimosus. J Exp Clin Cancer Res. 2002 Jun;21(2):213–217.
   PubMed Web of Science ®Google Scholar
• Bergendi L, Benes L, Durackova Z, Ferencik M. Chemistry, physiology and pathology of free radicals. Life Sci. 1999; 65(18–19):1865–1874.
   PubMedGoogle Scholar
• Bougle D, Vert P, Reichart E, Hartemann D, Heng E. Retinal superoxide dismutase activity in newborn kittens exposed to normobaric hyperoxia effect of vitamin E. Pediatric Research. 1982;16(5):400.
   PubMedGoogle Scholar
• Bigdeli MR, Hajizadeh S, Froozandeh M, Normobaric hyperoxia induces ischemic tolerance and upregulation of glutamate transporters in the rat brain and serum TNF-alpha level. Exp Neurol. 2008 Aug;212(2):298–306.
   PubMedGoogle Scholar
• Esmaili Dehaj M, Baharvand B, Rasoulian B, Delayed protective effects of hyperoxia against cardiac arrhythmias and infarction in anesthetized rats. J Surg Res. 2009 Jan; 151(1):55–61.
   PubMedGoogle Scholar
• Dong H, Xiong L, Zhu Z, Chen S, Hou L, Sakabe T. Preconditioning with hyperbaric oxygen and hyperoxia induces tolerance against spinal cord ischemia in rabbits. Anesthesiology. 2002 Apr;96(4):907–912.
   PubMedGoogle Scholar
• Atasoyu EM, Yildiz S, Bilgi O, Investigation of the role of hyperbaric oxygen therapy in cisplatin-induced nephrotoxicity in rats. Arch Toxicol. 2005 May;79(5):289–293.
   PubMedGoogle Scholar
• Greeger R, Windhorst U. Comprehensive human physiology. 1st ed. Berlin, Heidelberg: Springer-Verlag; 1996.
   Google Scholar
• Aydinoz S, Uzun G, Cermik H, Effects of different doses of hyperbaric oxygen on cisplatin-induced nephrotoxicity. Ren Fail. 2007;29(3):257–263.
   PubMed Web of Science ®Google Scholar
• Vera G, Chiarlone A, Cabezos PA, Pascual D, Martin MI, Abalo R. WIN 55,212-2 prevents mechanical allodynia but not alterations in feeding behaviour induced by chronic cisplatin in the rat. Life Sci. 2007 Jul 19;81(6): 468–479.
   PubMedGoogle Scholar
• Kim SH, Hong KO, Hwang JK, Park K-K. Xanthorrhizol has a potential to attenuate the high dose cisplatin-induced nephrotoxicity in mice. Food and Chemical Toxicology. 2005 Jan;43(1):117–122.
   PubMed Web of Science ®Google Scholar
• Yu YN, Chen H, Li Y. Protect effect of bicyclol on cisplatin-induced nephrotoxicity in mice. Arch Toxicol. 2009 Apr; 83(4):381–387.
   PubMedGoogle Scholar
• Tüközkan N, Erdamar H, Seven I, Anabilim GT, Dal A. Measurement of total malondialdehyde in plasma and tissues by high-performance liquid chromatography and thiobarbituric acid assay. Firat Tip Dergisi. 2006;11: 88–92.
   Google Scholar
• Gaedeke J, Fels LM, Bokemeyer C, Mengs U, Stolte H, Lentzen H. Cisplatin nephrotoxicity and protection by silibinin. Nephrol Dial Transplant. 1996 Jan;11(1):55–62.
   PubMedGoogle Scholar
• Teicher BA, Lazo JS, Sartorelli AC. Classification of antineoplastic agents by their selective toxicities toward oxygenated and hypoxic tumor cells. Cancer Res. 1981 Jan;41(1):73–81.
   PubMed Web of Science ®Google Scholar
• Alagoz T, Buller RE, Anderson B, Evaluation of hyperbaric oxygen as a chemosensitizer in the treatment of epithelial ovarian cancer in xenografts in mice. Cancer. 1995 May 1;75(9):2313–2322.
   PubMedGoogle Scholar
• Cannizzaro A, Verga Falzacappa CV, Martinelli M, Misiti S, Brunetti E, Bucci B. O(2/3) exposure inhibits cell progression affecting cyclin B1/cdk1 activity in SK-N-SH while induces apoptosis in SK-N-DZ neuroblastoma cells. J Cell Physiol. 2007 Oct;213(1):115–125.
   PubMedGoogle Scholar
• Stogner SW, Payne DK. Oxygen toxicity. Ann Pharmacother. 1992 Dec;26(12):1554–1562.
   PubMedGoogle Scholar